ANGINA PECTORIS or angina-like chest pain with a normal coronary arteriogram and positive EXERCISE TEST. The cause of the syndrome is unknown. While its recognition is of clinical importance, its prognosis is excellent. (Braunwald, Heart Disease, 4th ed, p1346; Jablonski Dictionary of Syndromes & Eponymic Diseases, 2d ed). It is different from METABOLIC SYNDROME X, a syndrome characterized by INSULIN RESISTANCE and HYPERINSULINEMIA, that has increased risk for cardiovascular disease.
The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.
The circulation of the BLOOD through the MICROVASCULAR NETWORK.
The continuation of the axillary artery; it branches into the radial and ulnar arteries.
Precordial pain at rest, which may precede a MYOCARDIAL INFARCTION.
The circulation of blood through the CORONARY VESSELS of the HEART.
Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components.
The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE.
A clinical syndrome characterized by the development of CHEST PAIN at rest with concomitant transient ST segment elevation in the ELECTROCARDIOGRAM, but with preserved exercise capacity.
The finer blood vessels of the vasculature that are generally less than 100 microns in internal diameter.
Persistent and reproducible chest discomfort usually precipitated by a physical exertion that dissipates upon cessation of such an activity. The symptoms are manifestations of MYOCARDIAL ISCHEMIA.

Enhanced exercise-induced hyperkalemia in patients with syndrome X. (1/151)

OBJECTIVES: The purpose of this study was to determine whether patients with syndrome X have altered potassium metabolism. BACKGROUND: Patients with syndrome X have angina pectoris and exercise induced ST segment depression on the electrocardiogram despite normal coronary angiograms. Increasing evidence suggests that myocardial ischemia is uncommon in these patients. Altered potassium metabolism causing interstitial potassium accumulation in the myocardium may be an alternative mechanism for chest pain and ST segment depression in syndrome X. METHODS: We compared the magnitude of exercise-induced hyperkalemia in 16 patients with syndrome X (12 female and four male, mean +/- SD age 53 +/- 6 years) and 15 matched healthy control subjects. The participants underwent a bicycle test at a fixed load of 75 W for 10 min, and blood samples were taken for analysis of potassium, catecholamines and lactate before, during and in the recovery period after exercise. In five patients with syndrome X, the test was repeated during alpha1 adrenoceptor blockade. RESULTS: Baseline concentrations of serum potassium, plasma catecholamines and plasma lactate were similar in patients and control subjects. The rate of exercise-induced increment of serum potassium was increased in the patients (70 +/- 29 vs. 30 +/- 21 micromol/liter/min in control subjects, p < 0.001). Six patients, who stopped before 10 min of exercise, showed very rapid increments in serum potassium concentration. Compared to the control subjects, patients also demonstrated larger increments in rate-pressure product, plasma norepinephrine and lactate concentrations during exercise. The rate of serum potassium increment correlated with the rate of plasma norepinephrine increment in the patients (r = 0.63, p < 0.02), but not in the control subjects (r = 0.01, p = 0.97). Blockade of alpha1 adrenoceptors decreased systolic blood pressure at baseline, but did not influence the increment of serum potassium, plasma catecholamines and lactate. CONCLUSIONS: Patients with syndrome X have enhanced exercise induced hyperkalemia in parallel with augmented increases of circulating norepinephrine and lactate. The prevailing mechanisms behind the abnormal potassium handling comprise sources distinct from alpha1-adrenoceptor activation.  (+info)

Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X. (2/151)

BACKGROUND: Impaired vasodilatation capacity in patients with angina pectoris and a normal coronary arteriogram (syndrome X [SX]) has been reported. Most studies report on the response in epicardial vessels. This does not necessarily reflect compromised myocardial microcirculation. Lack of the NO precursor L-arginine has been suggested as a possible cause. METHODS AND RESULTS: Myocardial blood flow (MBF) was measured, using PET, at rest (MBF-rest) and during intravenous dipyridamole (MBF-DIP) in 25 women (mean age 53+/-7 years) with SX. Thirty healthy volunteers served as controls. One group (A) consisted of 15 age-matched female volunteers (54+/-10 years). The other control group consisted of 15 young healthy women (B; 24+/-5 years). In 12 SX patients, MBF-rest and MBF during cold pressor testing were also measured after infusion of L-arginine (6.7 g/min for 45 minutes). The increase in MBF after cold pressor testing was similar in the SX group compared with controls. L-arginine did not affect MBF-rest (0.83+/-0.14 versus 0.89+/-0.13 mL. g-1. min-1) or MBF after cold pressor test (0.95+/-0.10 versus 1. 03+/-0.17 mL. g-1min-1). In contrast, the hyperemic response to DIP was blunted compared with the group A controls (1.68+/-0.49 versus 2. 34+/-0.45 mL. g-1. min-1, P<0.05); this resulted in a significant reduction of the coronary flow reserve in SX patients relative to controls (2.03+/-0.53 versus 2.96+/-0.63 mL. g-1. min-1, P<0.01). CONCLUSIONS: In patients with SX, the microcirculatory response to cold, reflecting the endothelium function, is normal and unaltered by intravenous L-arginine. This suggests preserved microcirculatory endothelial function. However, a markedly attenuated hyperemic flow and flow reserve after DIP suggest a dysfunction of the adenosine-mediated endothelium-independent vasodilatation at the microcirculatory level in these patients.  (+info)

Elevated endothelin concentrations are associated with reduced coronary vasomotor responses in patients with chest pain and normal coronary arteriograms. (3/151)

OBJECTIVES: The purpose of this study was to investigate the relationship between arterial and coronary sinus endothelin (ET) concentrations and coronary vasomotor responses during rapid atrial pacing in patients with chest pain and normal coronary arteriograms (CPNA). BACKGROUND: Plasma ET concentrations are significantly higher in CPNA patients than in healthy control subjects. METHODS: We investigated 19 carefully characterized CPNA patients (14 women; mean age 53 +/- 9 years) of whom 10 had positive electrocardiographic responses to exercise. The percentage fall in coronary vascular resistance (%d.CVR) after 10 min of rapid atrial pacing was determined using a thermodilution pacing catheter. Plasma ET concentrations were measured by radioimmunoassay on simultaneously drawn arterial and coronary sinus samples. RESULTS: No significant differences in ET concentrations were observed between men and women, but a strong statistical trend suggested that %d.CVR was lower in women than men (27[23 to 31]% vs. 34[29 to 45]%--median[interquartile range]; p = 0.07). Simple regression analysis including only the women (n = 14) suggested a significant relationship between baseline arterial ET concentrations and %d.CVR (R2 = 0.34; p = 0.06). Furthermore, stepwise multivariate regression analysis of the group as a whole indicated that both gender (p = 0.03) and baseline arterial ET concentration (p = 0.02) were independently predictive of %d.CVR (R2 = 0.44; overall p = 0.02); this relationship predicts that women with high ET levels would have the lowest %d.CVR during pacing. CONCLUSIONS: These data support the hypothesis that elevated ET activity may be associated with reduced coronary flow responses during rapid atrial pacing in CPNA patients.  (+info)

Endothelial and metabolic characteristics of patients with angina and angiographically normal coronary arteries: comparison with subjects with insulin resistance syndrome and normal controls. (4/151)

OBJECTIVES: This study was performed to characterize the endothelial and metabolic alterations of patients with angina and angiographically normal coronary arteries ("cardiac" syndrome X [CSX]) compared with subjects with insulin resistance syndrome ("metabolic" syndrome X [MSX]) and normal controls. BACKGROUND: Previous studies have found high endothelin-1 levels, impaired endothelium-dependent vasodilation and insulin resistance in patients with angina pectoris and angiographically normal coronary arteries. On the other hand, subjects with insulin resistance syndrome have shown high endothelin-1 levels. METHODS: Thirty-five subjects were studied: 13 patients with angina pectoris and angiographically normal coronary arteries (CSX group); 9 subjects with insulin resistance syndrome (MSX group) and 13 normal controls. All subjects received an acute intravenous bolus of insulin (0.1 U/kg) combined with a euglycemic clamp and forearm indirect calorimetry. Endothelin-1 levels, nitrite/nitrate (NOx) levels, end products of nitric oxide metabolism, glucose infusion rates (index of insulin sensitivity) and their incremental areas (deltaAUCs [area under curves]) were measured during this period. RESULTS: Basal endothelin-1 levels were higher in CSX and MSX groups than in normal controls (8.19 +/- 0.46 and 6.97 +/- 0.88 vs. 3.67 +/- 0.99 pg/ml; p < 0.01), while basal NOx levels were significantly higher in MSX group than in CSX and normal controls (36.5 +/- 4.0 vs. 24.2 +/- 3.3 and 26.8 +/- 3.2 mol/liter, p < 0.05). After insulin administration, the deltaAUCs of NOx (p < 0.05) were lower in CSX group than in MSX and normal controls, and the deltaAUCs of endothelin-1 were lower in group CSX than in normal controls. Glucose infusion rate was significantly lower in CSX and MSx groups than in normal controls (p < 0.01), suggesting that in both CSX and MSX groups insulin resistance is present. A positive correlation was found between the deltaAUCs of nitric oxide and the AUCs of glucose infusion rate. CONCLUSIONS: Blunted nitric oxide and endothelin responsiveness to intravenously infused insulin is a typical feature of patients with angina pectoris and angiographically normal coronary arteries and may contribute to the microvascular dysfunction observed in these subjects.  (+info)

Pseudoxanthoma elasticum with dipyridamole-induced coronary artery spasm: a case report. (5/151)

In patients with pseudoxanthoma elasticum, severe organic coronary artery stenosis often occurs without coronary risk factors. However, this report presents the case of a 49-year-old woman with pseudoxanthoma elasticum who had coronary artery spasm with an angiographically normal coronary artery. In addition, coronary artery spasm was provoked with dipyridamole thallium-201 cardiac imaging.  (+info)

Analgesic effects of adenosine in syndrome X are counteracted by theophylline: a double-blind placebo-controlled study. (6/151)

It has been proposed that adenosine mediates ischaemic pain in humans. Patients with cardiac Syndrome X are hypersensitive to potential pain stimuli, including adenosine. On the other hand, recent findings suggest that low-dose adenosine infusion may have analgesic effects. Our aim was to test two hypotheses: (1) that the analgesic effect of adenosine is peripheral in origin, and (2) that part of the hypersensitivity to pain of patients with cardiac Syndrome X results from a disturbed mechanism of adenosine analgesia. A total of 12 female Syndrome X patients and eight healthy age-matched female controls were studied in a randomized, double-blind and placebo-controlled study. Adenosine (70 microg/min) or placebo was infused into the forearm via an intra-arterial catheter. After 15 min of infusion, a tourniquet on the upper arm was inflated to 225 mmHg to ensure arterial occlusion. The patient then carried out dynamic handgrip work at 60 Hz. Pain or discomfort in the forearm was estimated continuously according to the Borg CR-10 scale. After the first test, theophylline was infused for 10 min intravenously at a dose of 5 mg/kg body weight. The ischaemic forearm test was then repeated. On a second occasion, the procedure was repeated with the opposite treatment (adenosine/placebo). Only six of 12 Syndrome X patients completed the protocol because of pain during the catheterization procedure or an inability to establish an intra-arterial line. The time to onset of pain in the working, ischaemic forearm was greater for subjects treated with adenosine than for those treated with placebo, both in those Syndrome X patients who tolerated catheterization (49+/-27 s compared with 32+/-18 s; P<0.03) and in healthy controls (40+/-19 s compared with 16+/-8 s; P<0.02). The time to maximum pain, limiting ischaemic work, was also greater with adenosine pretreatment both in Syndrome X patients (137+/-28 s compared with 106+/-28 s; P<0.03) and in healthy controls (109+/-31 compared with 82+/-18 s; P<0.01). After infusion of theophylline there was no difference between adenosine and placebo in either group. Intra-arterially infused adenosine had similar peripheral analgesic effects on experimentally induced muscular ischaemia in those female Syndrome X patients who tolerated intra-arterial catheterization and in healthy controls. Thus adenosine analgesia is counteracted by theophylline, suggesting that the effect is mediated by membrane-bound peripheral adenosine receptors.  (+info)

Role of the vascular endothelium in patients with angina pectoris or acute myocardial infarction with normal coronary arteries. (7/151)

Chest pain with normal coronary angiograms is a relatively common syndrome. The mode of presentation of this syndrome includes patients with syndrome X and patients with an acute myocardial infarction and angiographically normal coronary arteries. Different mechanisms have been proposed to elucidate the exact cause and to explain the various clinical presentations in these patients. Abnormalities of pain perception and the presence of oesophageal dysmotility have all been reported in patients with syndrome X. In situ thrombosis or embolization with subsequent clot lysis and recanalization, coronary artery spasm, cocaine abuse, and viral myocarditis have been described as potential mechanisms responsible for an acute myocardial infarction in patients with angiographically normal coronary arteries. Recent data suggest that both microvascular and epicardial endothelial dysfunction may play an important role in the pathophysiological mechanism of the syndrome of stable angina or acute myocardial infarction with normal coronary arteries.  (+info)

Negative stress echocardiographic responses in normotensive and hypertensive patients with angina pectoris, positive exercise stress testing, and normal coronary arteriograms. (8/151)

OBJECTIVES: To systematically compare the results of dobutamine stress echocardiography in matched groups of hypertensive and normotensive patients with anginal chest pain and normal coronary arteriograms (CPNA). SETTING: University hospital. SUBJECTS: 33 patients with exertional anginal chest pain, a positive exercise stress ECG, and a completely normal coronary arteriogram; 17 had a history of systemic hypertension (14 women; mean (SD) age 57 (6) years), and 16 had no hypertensive history (12 women; age 54 (9) years). METHODS: Ambulatory ECG monitoring, dobutamine stress echocardiography, and thallium-201 single photon emission computed tomography (SPECT) were performed in all subjects. RESULTS: All patients had normal left ventricular systolic function at rest and none fulfilled the criteria for ventricular hypertrophy. Eight normotensive patients and 10 hypertensive patients had perfusion abnormalities on thallium SPECT (p = 0.61). Dobutamine infusion reproduced anginal pain in seven normotensive and seven hypertensive patients (p = 0.88). ST segment depression was also recorded in eight normotensive patients and seven hypertensive patients (p = 0. 61). No patient in either group developed regional wall motion abnormalities during dobutamine stress echocardiography. CONCLUSIONS: Neither hypertensive nor normotensive CPNA patients developed regional wall motion abnormalities during dobutamine stress echocardiography, despite the high prevalence of scintigraphic perfusion defects in both groups and the presence of chest pain and ST segment depression. Thus myocardial ischaemia was not present in either group, or else dobutamine stress echocardiography is insensitive to ischaemia caused by microvascular dysfunction.  (+info)

Microvascular angina, also known as cardiac syndrome X or microvascular ischemia, is a type of angina (chest pain) that results from reduced blood flow to the heart muscle due to dysfunction in the small coronary arteries (microvasculature). These vessels are too small to be visualized during conventional diagnostic tests like coronary angiography.

The medical definition of microvascular angina is:

A clinical syndrome characterized by the presence of anginal chest pain, often accompanied by evidence of myocardial ischemia (insufficient blood flow to the heart muscle), in the absence of obstructive coronary artery disease on conventional diagnostic imaging. The underlying mechanism involves dysfunction and impaired regulation of the microvasculature, leading to reduced vasodilatory capacity, increased vasoconstriction, and ultimately, inadequate oxygen supply to meet the metabolic demands of the heart muscle.

Microvascular angina is more prevalent in women, especially those with risk factors such as hypertension, diabetes, hyperlipidemia, and smoking. Diagnosis often requires specialized testing like coronary flow reserve assessment using positron emission tomography (PET) or cardiac magnetic resonance imaging (MRI). Treatment typically involves a combination of lifestyle modifications, medications to improve blood vessel function and reduce chest pain, and sometimes, invasive treatments such as transmyocardial laser revascularization.

Angina pectoris is a medical term that describes chest pain or discomfort caused by an inadequate supply of oxygen-rich blood to the heart muscle. This condition often occurs due to coronary artery disease, where the coronary arteries become narrowed or blocked by the buildup of cholesterol, fatty deposits, and other substances, known as plaques. These blockages can reduce blood flow to the heart, causing ischemia (lack of oxygen) and leading to angina symptoms.

There are two primary types of angina: stable and unstable. Stable angina is predictable and usually occurs during physical exertion or emotional stress when the heart needs more oxygen-rich blood. The pain typically subsides with rest or after taking prescribed nitroglycerin medication, which helps widen the blood vessels and improve blood flow to the heart.

Unstable angina, on the other hand, is more severe and unpredictable. It can occur at rest, during sleep, or with minimal physical activity and may not be relieved by rest or nitroglycerin. Unstable angina is considered a medical emergency, as it could indicate an imminent heart attack.

Symptoms of angina pectoris include chest pain, pressure, tightness, or heaviness that typically radiates to the left arm, neck, jaw, or back. Shortness of breath, nausea, sweating, and fatigue may also accompany angina symptoms. Immediate medical attention is necessary if you experience chest pain or discomfort, especially if it's new, severe, or persistent, as it could be a sign of a more serious condition like a heart attack.

Microcirculation is the circulation of blood in the smallest blood vessels, including arterioles, venules, and capillaries. It's responsible for the delivery of oxygen and nutrients to the tissues and the removal of waste products. The microcirculation plays a crucial role in maintaining tissue homeostasis and is regulated by various physiological mechanisms such as autonomic nervous system activity, local metabolic factors, and hormones.

Impairment of microcirculation can lead to tissue hypoxia, inflammation, and organ dysfunction, which are common features in several diseases, including diabetes, hypertension, sepsis, and ischemia-reperfusion injury. Therefore, understanding the structure and function of the microcirculation is essential for developing new therapeutic strategies to treat these conditions.

The brachial artery is a major blood vessel in the upper arm. It supplies oxygenated blood to the muscles and tissues of the arm, forearm, and hand. The brachial artery originates from the axillary artery at the level of the shoulder joint and runs down the medial (inner) aspect of the arm, passing through the cubital fossa (the depression on the anterior side of the elbow) where it can be palpated during a routine blood pressure measurement. At the lower end of the forearm, the brachial artery bifurcates into the radial and ulnar arteries, which further divide into smaller vessels to supply the hand and fingers.

Unstable angina is a term used in cardiology to describe chest pain or discomfort that occurs suddenly and unexpectedly, often at rest or with minimal physical exertion. It is caused by an insufficient supply of oxygen-rich blood to the heart muscle due to reduced blood flow, typically as a result of partial or complete blockage of the coronary arteries.

Unlike stable angina, which tends to occur predictably during physical activity and can be relieved with rest or nitroglycerin, unstable angina is more severe, unpredictable, and may not respond to traditional treatments. It is considered a medical emergency because it can be a sign of an impending heart attack or other serious cardiac event.

Unstable angina is often treated in the hospital with medications such as nitroglycerin, beta blockers, calcium channel blockers, and antiplatelet agents to improve blood flow to the heart and prevent further complications. In some cases, more invasive treatments such as coronary angioplasty or bypass surgery may be necessary to restore blood flow to the affected areas of the heart.

Coronary circulation refers to the circulation of blood in the coronary vessels, which supply oxygenated blood to the heart muscle (myocardium) and drain deoxygenated blood from it. The coronary circulation system includes two main coronary arteries - the left main coronary artery and the right coronary artery - that branch off from the aorta just above the aortic valve. These arteries further divide into smaller branches, which supply blood to different regions of the heart muscle.

The left main coronary artery divides into two branches: the left anterior descending (LAD) artery and the left circumflex (LCx) artery. The LAD supplies blood to the front and sides of the heart, while the LCx supplies blood to the back and sides of the heart. The right coronary artery supplies blood to the lower part of the heart, including the right ventricle and the bottom portion of the left ventricle.

The veins that drain the heart muscle include the great cardiac vein, the middle cardiac vein, and the small cardiac vein, which merge to form the coronary sinus. The coronary sinus empties into the right atrium, allowing deoxygenated blood to enter the right side of the heart and be pumped to the lungs for oxygenation.

Coronary circulation is essential for maintaining the health and function of the heart muscle, as it provides the necessary oxygen and nutrients required for proper contraction and relaxation of the myocardium. Any disruption or blockage in the coronary circulation system can lead to serious consequences, such as angina, heart attack, or even death.

The endothelium is a thin layer of simple squamous epithelial cells that lines the interior surface of blood vessels, lymphatic vessels, and heart chambers. The vascular endothelium, specifically, refers to the endothelial cells that line the blood vessels. These cells play a crucial role in maintaining vascular homeostasis by regulating vasomotor tone, coagulation, platelet activation, inflammation, and permeability of the vessel wall. They also contribute to the growth and repair of the vascular system and are involved in various pathological processes such as atherosclerosis, hypertension, and diabetes.

Vasodilation is the widening or increase in diameter of blood vessels, particularly the involuntary relaxation of the smooth muscle in the tunica media (middle layer) of the arteriole walls. This results in an increase in blood flow and a decrease in vascular resistance. Vasodilation can occur due to various physiological and pathophysiological stimuli, such as local metabolic demands, neural signals, or pharmacological agents. It plays a crucial role in regulating blood pressure, tissue perfusion, and thermoregulation.

Angina pectoris, variant (also known as Prinzmetal's angina or vasospastic angina) is a type of chest pain that results from reduced blood flow to the heart muscle due to spasms in the coronary arteries. These spasms cause the arteries to narrow, temporarily reducing the supply of oxygen-rich blood to the heart. This can lead to symptoms such as chest pain, shortness of breath, and fatigue.

Variant angina is typically more severe than other forms of angina and can occur at rest or with minimal physical exertion. It is often treated with medications that help relax the coronary arteries and prevent spasms, such as calcium channel blockers and nitrates. In some cases, additional treatments such as angioplasty or bypass surgery may be necessary to improve blood flow to the heart.

It's important to note that chest pain can have many different causes, so it is essential to seek medical attention if you experience any symptoms of angina or other types of chest pain. A healthcare professional can help determine the cause of your symptoms and develop an appropriate treatment plan.

Microvessels are the smallest blood vessels in the body, including capillaries, venules, and arterioles. They form a crucial part of the circulatory system, responsible for delivering oxygen and nutrients to tissues and organs while removing waste products. Capillaries, the tiniest microvessels, facilitate the exchange of substances between blood and tissue cells through their thin walls. Overall, microvessels play a vital role in maintaining proper organ function and overall health.

Stable angina is a type of chest pain or discomfort that typically occurs during physical exertion or emotional stress. It is caused by reduced blood flow to the heart muscle, which can occur when the coronary arteries become narrowed or blocked due to the buildup of cholesterol and other substances (a condition known as atherosclerosis).

The symptoms of stable angina are usually predictable and may include chest pain or discomfort that is:

* Described as a squeezing, pressure, heaviness, or tightness in the chest
* Typically located in the center of the chest, but may radiate to the shoulders, arms, neck, jaw, or back
* Lasts for a few minutes and is usually relieved by rest or nitroglycerin

Stable angina is considered "stable" because the symptoms tend to occur predictably and can be managed with medication, lifestyle changes, and sometimes medical procedures such as angioplasty or bypass surgery. However, it is still a serious condition that requires proper diagnosis and treatment to prevent complications such as heart attack or stroke.

Microvascular angina, previously known as cardiac syndrome X, is angina (chest pain) with signs associated with decreased blood ... This is a distinct diagnosis from variant angina. While there is no formal definition of microvascular angina, the general ... variant/vasospastic angina, coronary artery spasm) which has similar symptoms. Chest pain caused by microvascular angina is ... Microvascular angina is a chronic long term condition which increases the risk of heart attack and other cardiac events such as ...
Microvascular Angina - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the MSD Manuals - Medical ... Microvascular angina (previously known as syndrome X) is cardiac microvascular dysfunction or constriction causing angina in ... This disorder should not be confused with variant angina Variant Angina Variant angina is angina pectoris secondary to ... Microvascular Angina (Angina With no Obstructive Coronary Artery Disease [ANOCA]). By Ranya N. Sweis , MD, MS, Northwestern ...
OFTEN NEGLECTED AND UNDIAGNOSED CAUSE OF WOMENS CHEST PAIN - CORONARY MICROVASCULAR ANGINA (SYNDROME X). by Dr Simone , Feb 2 ... Microvascular angina affects mainly women, and occurs predominately in postmenopausal women. These women are often neglected ...
This research should document the prevalence of microvascular spasm as well the different endotypes of coronary microvascular ... Coronary microvascular angina: a review. *Prediction models in angina: a review. *Angina resolution and percutaneous coronary ...
Categories UpdatesTags cardiology, chest pain, microvascular angina Post navigation. 53-Year-Old Stroke Survivor : "Im a new ... Microvascular Angina: My Story. September 23, 2021. September 23, 2021. by Jill Ross ... It wasnt until 2018, when I was referred back to Cardiology, that an MRI scan showed that I had microvascular angina, which is ...
Doppler Echocardiography Assessment of Coronary Microvascular Function in Patients With Angina and No Obstructive Coronary ... Microvascular Function in Patients interventions in angina patients with low CFVR were discussed, and key research With Angina ... microvascular angina; TTDE, transthoracic Doppler echocardiography; VSA, vasospastic angina. Frontiers in Cardiovascular ... Doppler Echocardiography Assessment of Coronary Microvascular Function in Patients With Angina and No Obstructive Coronary ...
... has increasingly been recognised through the detection of microvascular ... has increasingly been recognised through the detection of microvascular angina. Microvascular angina presents a risk factor for ... with 4 in 5 patients with microvascular angina are thought to have coronary microvascular dysfunction. Yet, there exists little ... aimed to define the diagnosis criteria and management guidelines of microvascular angina. ...
... how to diagnose Angina and what are some quick self-help remedies. Find out what can cause angina and how you can prevent one ... Microvascular angina. Stable Angina. Stable angina is the most common form of angina. It occurs when one of the major arteries ... Microvascular Angina. This is the rarest form of angina and is a symptom of the disease known as Coronary Microvascular Disease ... Symptoms of Microvascular Angina. This type of angina happens when you are going through your daily routine or when you are ...
Angina is chest pain or discomfort when there is not enough blood flow to your heart muscle. Learn about angina symptoms and ... Microvascular Angina (American Heart Association) * Prinzmetals or Prinzmetal Angina, Variant Angina, and Angina Inversa ( ... ClinicalTrials.gov: Angina Pectoris (National Institutes of Health) * ClinicalTrials.gov: Microvascular Angina (National ... Angina Pectoris (Stable Angina) (American Heart Association) * What Is Angina? (National Heart, Lung, and Blood Institute) Also ...
First international study to describe characteristics and prognosis for microvascular angina 27 May 2021 ... First author of the study and member of the COVADIS Group, Professor Hiroaki Shimokawa, said: "Microvascular angina is an under ... 1] "Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study ... Thus, the total number of angina patients is about 21 million in Europe. As several studies have shown that about 50% of angina ...
Microvascular Angina Overview. Microvascular angina (chest pain) is a type of angina that is caused by problems in the smallest ... Discover more about the emerging Microvascular Angina drugs @ Microvascular AnginaTreatment Drugs. Microvascular Angina ... Leading Microvascular Angina companies developing novel drug candidates to improve the Microvascular Angina treatment landscape ... Find out more about the Microvascular Angina treatment options in development @ Microvascular Angina Clinical Trials ...
... microvascular angina; (2) vasospastic angina; (3) mixed microvascular angina and vasospastic angina; (4) obstructive epicardial ... microvascular angina, vasospastic angina, mixed microvascular/vasospastic angina, obstructive epicardial coronary artery ... Coronary Microvascular Angina Cardiac MRI; CorMicA, coronary microvascular angina. ... Systemic microvascular dysfunction in microvascular and vasospastic angina. Eur Heart J 2018.doi:10.1093/eurheartj/ehy529 ...
This is called microvascular angina or small vessel angina. Microvascular angina is often underdiagnosed because confirming the ... Microvascular Angina. Angina is a type of chest pain caused by lack of blood flow to the heart. Most people with angina have ... What Causes Microvascular Angina?. The cause of microvascular angina is not fully understood, but it is thought that the very ... Treating Microvascular Angina Patients with microvascular angina have a worse prognosis than the general population, therefore ...
Systemic microvascular dysfunction in microvascular and vasospastic angina. Eur. Heart J. 2018, 39, 4086-4097. [Google Scholar ...
Angina pectoris (AP) represents the clinical syndrome occurring when myocardial oxygen demand exceeds supply. The term is ... Another possibility is that perfusion is decreased through microvascular circulation. Spasm or intermittent narrowing of this ... Prinzmetal angina or variant angina occurs as a result of transient coronary artery spasms. These spasms can occur either at ... encoded search term (Angina Pectoris in Emergency Medicine) and Angina Pectoris in Emergency Medicine What to Read Next on ...
Angina is a common presenting symptom (typically, chest pain) among patients with coronary artery disease. ... Angina pectoris is the result of myocardial ischemia caused by an imbalance between myocardial blood supply and oxygen demand. ... Angina due to dysfunction of small coronary arteries and arterioles is called microvascular angina. Several diseases, such as ... 8] Syndrome X is believed to be caused by microvascular angina. Multiple mechanisms may be responsible for this syndrome, ...
Tampa General Hospital is the highest volume center for Coronary Microvascular Dysfunction (CMD) diagnosis and therapy in the ... 50-65% of patients with angina with non-obstructive coronary artery disease (NOCAD) are believed to have Coronary Microvascular ... Diagnosis of Coronary Microvascular Dysfunction At Tampa General Hospital, our team uses a more detailed patient evaluation ... As part of our CMD diagnosis, we also routinely test for Vasospastic Angina with the use of intracoronary acetylcholine, a ...
Microvascular Angina / Women and Heart Disease (1.0 CE). *Define the pathophysiology and clinical presentation, and prognosis ... Microvascular Angina / Women and Heart Disease - Eileen Handberg, PhD, APRN (UF Shands, Gainsville). ...
cardiac syndrome X, CMR, coronary sinus flow, global myocardial perfusion, INOCA, microvascular angina. in Clinical Physiology ... Background: Patients with chest pain may have normal coronary arteries and suffer from microvascular angina (MVA). The aim of ... Background: Patients with chest pain may have normal coronary arteries and suffer from microvascular angina (MVA). The aim of ... Patients with chest pain may have normal coronary arteries and suffer from microvascular angina (MVA). The aim of this study ...
ODonoghue interviews the sham PCI controlled trial investigators on the role of stents in the management of stable angina in ... One of the things that could have contributed is that the Angina Symptoms Score data gave us a daily score of their angina ... However, what we can say is that we had excellent resolution of ischemia in our PCI arm, and therefore if the microvascular ... Residual Angina ODonoghue: Chris, one of the interesting things to come from ORBITA-2 was the fact that even after PCI, the ...
2021) Rationale and design of the Medical Research Council Precision medicine with Zibotentan in microvascular angina (PRIZE) ... 2020) Rationale and design of the Medical Research Council precision medicine with Zibotentan in microvascular angina (PRIZE) ... 2020) Rationale and design of the Medical Research Council precision medicine with Zibotentan in microvascular angina (PRIZE) ... 2021) Rationale and design of the Medical Research Council Precision medicine with Zibotentan in microvascular angina (PRIZE) ...
Clinical Topics: Prevention, Stable Ischemic Heart Disease, Chronic Angina Keywords: Chest Pain, Microvascular Angina, ... 3) Abnormal index of microcirculatory resistance/hyperemic microvascular resistance. 4) Normal CFR and microvascular resistance ... CCBs should be used first-line for epicardial coronary spasm and may be beneficial for microvascular spasm. When angina ... Samuels BA, Shah SM, Widmer J, et al., on behalf of the Microvascular Network (MVN). Citation:. Comprehensive Management of ...
Microvascular angina (MVA) is characterized by anginal chest pain, an abnormal stress test, and normal coronary arteries on ... Understanding of chest pain in microvascular disease proved by cardiac magnetic resonance image (UMPIRE): study protocol for a ...
Angina - Over time, high blood pressure can lead to heart disease or microvascular disease (MVD). Angina, or chest pain, is a ... Chest pain, also called angina. *Heart attack, which occurs when the blood supply to the heart is blocked and heart muscle ...
... and coronary artery disease and microvascular angina. Angiology. 67:846-53. DOI: 10.1177/0003319715625827. PMID: 26744512. ...
Microvascular and macrovascular complications of diabetes. Clin Diabetes (2008) 26:77-82. doi: 10.2337/diaclin.26.2.77 ... The diagnosis of coronary heart disease (CHD) was based on a history of angina pectoris, myocardial infarction, percutaneous ... Macrovascular and microvascular complications of diabetes among the groups. The prevalence of diabetic macrovascular and ... The data of macrovascular and microvascular complications of diabetes were also collected based on the available information. ...
Abnormal function of tiny branch arteries without narrowing of larger arteries (called microvascular dysfunction or Syndrome X) ... Unstable angina. Accelerating angina; New-onset angina; Angina - unstable; Progressive angina; CAD - unstable angina; Coronary ... People with unstable angina are at higher risk of having a heart attack.. Angina. Angina is a type of chest discomfort or pain ... Angina - illustration Angina is a specific type of pain in the chest caused by inadequate blood flow through the blood vessels ...
Microvascular Myocardial Ischemia in Patients With Diabetes Without Obstructive Coronary Stenosis and Its Association With ... and its relationship with angina. Materials and Methods: Diabetic patients and an intermediate-to-high... ... Objective: To investigate the incidence of microvascular myocardial ischemia in diabetic patients without obstructive coronary ... Angina Yu Y, Yang W, Dai X, Yu L, Lan Z, Ding X, Zhang J ...
The Mentice Simulator allows out-of-lab hands-on experience learning how to optimise epicardial and microvascular measurements. ...

No FAQ available that match "microvascular angina"

No images available that match "microvascular angina"